SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'

Credit: IndiaTimes- Published 2 weeks ago

SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency confirms Vaxzevria discontinuation in EU.

👓 View full article:

💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

1 in 3 Covaxin recipients hit by adverse events: Study

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..

Credit: IndiaTimes - Published 3 days ago

Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP 02:44

Credit: Oneindia - Published 3 weeks ago